Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Diabetes Control"'
Autor:
Sheeba Ba Aqeel, Minghao Ye, Jan Wysocki, Alejandro Sanchez, Ahmed Khattab, Enrique Lores, Alfred Rademaker, Xiaoyu Gao, Ionut Bebu, Robert G. Nelson, Mark Molitch, Daniel Batlle, For the Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study
Publikováno v:
Physiological Reports, Vol 7, Iss 19, Pp n/a-n/a (2019)
Abstract We examined if urinary angiotensinogen (uAOG), a marker of intrarenal renin‐angiotensin system activity, antedates stage 3 chronic kidney disease (CKD) using samples from participants in the Diabetes Control and Complications Trial (DCCT)
Externí odkaz:
https://doaj.org/article/3691b28e0c0d4b26a6ef3f164ade6e7b
Autor:
Diabetes Control, Andrew J. Barkmeier, William V. Tamborlane, Xiaoyu Gao, Ionut Bebu, John M. Lachin, Arup Das, Lisa Olmos de Koo, Dean P. Hainsworth, Lloyd Paul Aiello, Complications Trial
Publikováno v:
Ophthalmology. 128:554-560
Purpose To determine the relationship between refractive error and diabetic retinopathy (DR). Design Clinical trial. Participants Type I diabetes individuals with serial refractive error and DR stage measurements over 30 years in the Diabetes Control
Autor:
Diabetes Control, Mary K. Oerline, Barbara H. Braffett, Complications Trial, Hunter Wessells, Rodica Pop-Busui, Shivani Bakre, Aruna V. Sarma, Sarah K. Holt
Publikováno v:
Neurourol Urodyn
Aims Urinary incontinence (UI) in women is a dynamic condition with numerous risk factors yet most studies have focused on examining its prevalence at a single time. The objective of this study was to describe the long-term time course of UI in women
Autor:
Lachin, John M., Bebu, Ionut, Gao, Xiaoyu, Nathan, David M., Zinman, Bernard, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group
Publikováno v:
Diabetes Care; Oct2022, Vol. 45 Issue 10, p2445-2448, 4p
Autor:
W. Timothy Garvey, Complications Trial, Jamie R. Wood, Petar Alaupovic, Arpita Basu, Timothy J. Lyons, David S. Schade, Julie A. Stoner, Ying Zhang, Richard L. Klein, Alicia J. Jenkins, Diabetes Control, Maria F. Lopes-Virella
Publikováno v:
Journal of Lipid Research, Vol 59, Iss 5, Pp 872-883 (2018)
Circulating apolipoprotein-defined lipoprotein subclasses (ADLS) and apolipoproteins predict vascular events in the general and type 2 diabetes populations, but data in T1D are limited. We examined associations of ADLS, serum apolipoproteins, and con
Publikováno v:
Langenbeck's Archives of Surgery. 402:873-883
Indications for total pancreatectomy (TP) have increased, including for diffuse main duct intrapapillary mucinous neoplasms of the pancreas and malignancy; therefore, the need persists for surgeons to develop appropriate endocrine post-operative mana
Autor:
Basu, Arpita, Bebu, Ionut, Jenkins, Alicia J, Stoner, Julie A, Zhang, Ying, Klein, Richard L, Lopes-Virella, Maria F, Garvey, W Timothy, Budoff, Matthew J, Alaupovic, Petar, Lyons, Timothy J, Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications Research Group
Publikováno v:
Journal of lipid research, vol 60, iss 8
APOB, APOC3, and APOE and apolipoprotein-defined lipoprotein subclasses (ADLSs; based on qualitative apolipoprotein complement) have been associated with dyslipidemia and CVD. Our main objective was to define associations of serum apolipoproteins and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::38e575b68ab955c384417856db36ac21
https://escholarship.org/uc/item/8046r195
https://escholarship.org/uc/item/8046r195
Publikováno v:
Diabetes Care
OBJECTIVE Historically, mortality in type 1 diabetes has exceeded that in the general population. We compared mortality in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study cohort
Publikováno v:
Diabetes Care
OBJECTIVE Early initiation of intensive diabetes therapy aimed at achieving near-normal glycemia reduces the early development of vascular complications in type 1 diabetes. We now assess whether intensive therapy compared with conventional therapy du
Autor:
Van Zuydam, Natalie R, Ahlqvist, Emma, Sandholm, Niina, Deshmukh, Harshal, Rayner, N William, Abdalla, Moustafa, Ladenvall, Claes, Ziemek, Daniel, Fauman, Eric, Robertson, Neil R, McKeigue, Paul M, Valo, Erkka, Forsblom, Carol, Harjutsalo, Valma, Finnish Diabetic Nephropathy Study (FinnDiane), Perna, Annalisa, Rurali, Erica, Marcovecchio, M Loredana, Igo, Robert P, Salem, Rany M, Perico, Norberto, Lajer, Maria, Käräjämäki, Annemari, Imamura, Minako, Kubo, Michiaki, Takahashi, Atsushi, Sim, Xueling, Liu, Jianjun, Van Dam, Rob M, Jiang, Guozhi, Tam, Claudia HT, Luk, Andrea OY, Lee, Heung Man, Lim, Cadmon KP, Szeto, Cheuk Chun, So, Wing Yee, Chan, Juliana CN, Group, Hong Kong Diabetes Registry Theme-Based Research Scheme Project, Ang, Su Fen, Dorajoo, Rajkumar, Wang, Ling, Clara, Tan Si Hua, McKnight, Amy-Jayne, Duffy, Seamus, Warren 3 And Genetics Of Kidneys In Diabetes (GoKinD) Study Group, Pezzolesi, Marcus G, GENIE (GEnetics Of Nephropathy An International Effort) Consortium, Marre, Michel, Gyorgy, Beata, Hadjadj, Samy, Hiraki, Linda T, Diabetes Control And Complications Trial (DCCT)/Epidemiology Of Diabetes Interventions And Complications (EDIC) Research Group, Ahluwalia, Tarunveer S, Almgren, Peter, Schulz, Christina-Alexandra, Orho-Melander, Marju, Linneberg, Allan, Christensen, Cramer, Witte, Daniel R, Grarup, Niels, Brandslund, Ivan, Melander, Olle, Paterson, Andrew D, Tregouet, David, Maxwell, Alexander P, Lim, Su Chi, Ma, Ronald CW, Tai, E Shyong, Maeda, Shiro, Lyssenko, Valeriya, Tuomi, Tiinamaija, Krolewski, Andrzej S, Rich, Stephen S, Hirschhorn, Joel N, Florez, Jose C, Dunger, David, Pedersen, Oluf, Hansen, Torben, Rossing, Peter, Remuzzi, Giuseppe, SUrrogate Markers For Micro- And Macrovascular Hard Endpoints For Innovative Diabetes Tools (SUMMIT) Consortium, Brosnan, Mary Julia, Palmer, Colin NA, Groop, Per-Henrik, Colhoun, Helen M, Groop, Leif C, McCarthy, Mark I
Publikováno v:
Diabetes, vol 67, iss 7
Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1622ca6768b5e956124329f7cbf05537
https://escholarship.org/uc/item/37m0v97n
https://escholarship.org/uc/item/37m0v97n